Literature DB >> 11829425

Occurrence and prognostic implications of micrometastases in lymph nodes from patients with submucosal gastric carcinoma.

Hong-Jo Choi1, Yun-Ki Kim, Young-Hoon Kim, Sang-Soon Kim, Sook-Hee Hong.   

Abstract

BACKGROUND: The aims of this study were to assess the incidence of micrometastases of lymph nodes in patients with early gastric cancer invading the submucosal layer and to investigate the correlation between nodal micrometastases and malignancy potential to determine whether micrometastases of lymph nodes have prognostic significance, by use of an anticytokeratin immunohistochemical technique.
METHODS: A total of 2272 lymph nodes taken from 88 patients (25.8 per case) were assessed by immunohistochemical technique by use of monoclonal anti-human cytokeratin 8 antibodies. Clinicopathologic parameters and prognosis were compared between patients with and without micrometastases.
RESULTS: The incidence of nodal involvement by tumor cells in 88 patients with submucosal gastric cancer increased from 19.3% (17 patients) by hematoxylin-eosin (H&E) staining to 31.8% (28 patients) by cytokeratin immunostaining. The rate of positive node in this study increased from 1.0% (23 of 2272 nodes) by H&E staining to 2.5% (57 of 2272 nodes) by immunostaining (P = .0002). No correlation was observed between the incidence of lymph node micrometastases and various clinicopathologic parameters, including tumor site and size, histological differentiation, Lauren classification, gross tumor type, vascular and lymphatic invasion, and perineural invasion. There was no difference in disease-free survival, estimated by the Kaplan-Meier life-table method, between the micrometastasis-negative and -positive groups (95% and 92.9%, respectively). Multivariate analyses showed that tumor size and diffuse subtype by the Lauren classification were significant factors for survival time (P = .0042 and .014, respectively).
CONCLUSIONS: Immunohistochemical staining with an anticytokeratin antibody seems to be of little prognostic value in patients with submucosal gastric carcinoma. Thus, this immunostaining technique does not offer a significant benefit of different strategies for additional therapy or follow-up over conventional pathologic staging with H&E staining.

Entities:  

Mesh:

Year:  2002        PMID: 11829425     DOI: 10.1245/aso.2002.9.1.13

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  26 in total

1.  Lymph node, peritoneal and bone marrow micrometastases in gastric cancer: Their clinical significance.

Authors:  John Griniatsos; Othon Michail; Nikoletta Dimitriou; Ioannis Karavokyros
Journal:  World J Gastrointest Oncol       Date:  2012-02-15

Review 2.  [Minimal residual tumor in gastrointestinal carcinoma. Relevance to prognosis and oncologic surgical consequences].

Authors:  S Gretschel; A Bembenek; T Schulze; W Kemmner; P M Schlag
Journal:  Chirurg       Date:  2006-12       Impact factor: 0.955

Review 3.  Impact of lymph node micrometastasis on gastric carcinoma prognosis: a meta-analysis.

Authors:  Yong-Ji Zeng; Chun-Dong Zhang; Dong-Qiu Dai
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

4.  Confirmation of the posterior gastric artery using multi-detector row computed tomography.

Authors:  Takehiro Okabayashi; Michiya Kobayashi; Satoshi Morishita; Takeki Sugimoto; Toyokazu Akimori; Tsutomu Namikawa; Ken Okamoto; Norihiro Hokimoto; Keijiro Araki
Journal:  Gastric Cancer       Date:  2005       Impact factor: 7.370

5.  Intraoperative diagnosis of lymph node metastasis by transcription-reverse transcription concerted reaction assay in gastric cancer.

Authors:  Ryouichi Hirayama; Akiyoshi Seshimo; Kunitomo Miyake; Masako Nishizawa; Shingo Kameoka
Journal:  Int J Clin Oncol       Date:  2013-06-14       Impact factor: 3.402

6.  Occult Tumour Cells in Lymph Nodes from Gastric Cancer Patients: Should Isolated Tumour Cells Also Be Considered?

Authors:  A Tavares; X Wen; J Maciel; F Carneiro; M Dinis-Ribeiro
Journal:  Ann Surg Oncol       Date:  2020-05-04       Impact factor: 5.344

7.  Concepts, rationale, and current outcomes of less invasive surgical strategies for early gastric cancer: data from a quarter-century of experience in a single institution.

Authors:  Shouji Shimoyama; Yasuyuki Seto; Hidemitsu Yasuda; Ken-ichi Mafune; Michio Kaminishi
Journal:  World J Surg       Date:  2005-01       Impact factor: 3.352

8.  Gastric carcinoma: stage migration by immunohistochemically detected lymph node micrometastases.

Authors:  Theresa L A Jeuck; Christian Wittekind
Journal:  Gastric Cancer       Date:  2014-02-19       Impact factor: 7.370

9.  Prediction of risk factors for lymph node metastasis in early gastric cancer.

Authors:  Gang Ren; Rong Cai; Wen-Jie Zhang; Jin-Ming Ou; Ye-Ning Jin; Wen-Hua Li
Journal:  World J Gastroenterol       Date:  2013-05-28       Impact factor: 5.742

10.  Occult disseminated tumor cells in lymph nodes of patients with gastric carcinoma. A critical appraisal of assessment and relevance.

Authors:  Peter Scheunemann; Nikolas H Stoecklein; Kai Hermann; Alexander Rehders; Claus F Eisenberger; Wolfram T Knoefel; Stefan B Hosch
Journal:  Langenbecks Arch Surg       Date:  2008-07-15       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.